Intracellular localization of amyloid-β peptide in SH-SY5Y neuroblastoma cells

Journal of Alzheimer's Disease

Volumn 37, Issue 4, 2013, Pages 713-733

  Zheng, Lin ^a   Calvo Garrido, Javier ^a   Hallbeck, Martin ^b   Hultenby, Kjell ^a   Marcusson, Jan ^b   Cedazo Minguez, Angel ^a   Terman, Alexei ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; amyloid protein; endosomes; exocytosis; lysosomes

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; OLIGOMER; TETANUS TOXIN;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL ORGANELLE; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENDOSOME; EXOCYTOSIS; GOLGI COMPLEX; HUMAN; HUMAN CELL; HYPEROXIA; IMMUNOELECTRON MICROSCOPY; LYSOSOME; MITOCHONDRION; MULTIVESICULAR BODY; MUTATIONAL ANALYSIS; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RUMINANT STOMACH; SECRETORY VESICLE;

ALZHEIMER'S DISEASE; AMYLOID Β-PROTEIN; ENDOSOMES; EXOCYTOSIS; LYSOSOMES;

AMYLOID BETA-PEPTIDES; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; INTRACELLULAR FLUID; NEUROBLASTOMA;

EID: 84892736202     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-122455     Document Type: Article

References (71)

1. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer's disease. Lancet 377, 1019-1031.
2. Mangialasche F, Solomon A,Winblad B, Mecocci P, Kivipelto M(2010) Alzheimer's disease: Clinical trials and drug development. Lancet Neurol 9, 702-716.
3. Thal LJ (2006) Prevention of Alzheimer disease. Alzheimer Dis Assoc Disord 20, S97-S99.
4. Selkoe DJ (2001) Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev 81, 741-766.
5. Hartmann T, Bieger SC, Bruhl B, Tienari PJ, Ida N, Allsop D, Roberts GW, Masters CL, Dotti CG, Unsicker K, Beyreuther K (1997) Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. Nat Med 3, 1016-1020.
6. Cook DG, Forman MS, Sung JC, Leight S, Kolson DL, Iwatsubo T, Lee VM, Doms RW(1997) Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat Med 3, 1021-1023.
7. Greenfield JP, Xu H, Greengard P, Gandy S, Seeger M (1999) Generation of the amyloid-beta peptide N terminus in Saccharomyces cerevisiae expressing human Alzheimer's amyloid-beta precursor protein. J Biol Chem 274, 33843- 33846.
8. Greenfield JP, Tsai J, Gouras GK, Hai B, Thinakaran G, Checler F, Sisodia SS, Greengard P,XuH(1999) Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc Natl Acad Sci U S A 96, 742-747.
9. Xu H, SweeneyD,Wang R, Thinakaran G, LoAC, Sisodia SS, Greengard P, Gandy S (1997) Generation of Alzheimer betaamyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc Natl Acad Sci U S A 94, 3748-3752.
10. Khvotchev M, Sudhof TC (2004) Proteolytic processing of amyloid-beta precursor protein by secretases does not require cell surface transport. J Biol Chem 279, 47101-47108.
11. Cataldo AM, Petanceska S, Terio NB, Peterhoff CM, Durham R, Mercken M, Mehta PD, Buxbaum J, Haroutunian V, Nixon RA (2004) Abeta localization in abnormal endosomes: Association with earliest Abeta elevations in AD and Down syndrome. Neurobiol Aging 25, 1263-1272.
12. Grbovic OM, Mathews PM, Jiang Y, Schmidt SD, Dinakar R, Summers-Terio NB, Ceresa BP, Nixon RA, Cataldo AM (2003) Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production. J Biol Chem 278, 31261-31268.
13. Takahashi RH, Almeida CG, Kearney PF, Yu F, Lin MT,Milner TA, Gouras GK (2004) Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 24, 3592-3599.
14. Hansson Petersen CA, Alikhani N, Behbahani H, Wiehager B, Pavlov PF, Alafuzoff I, Leinonen V, Ito A, Winblad B, Glaser E, Ankarcrona M (2008) The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci U S A 105, 13145-13150.
15. Tarassishin L, Yin YI, Bassit B, Li YM (2004) Processing of Notch and amyloid precursor protein by gamma-secretase is spatially distinct. Proc Natl Acad SciUS A 101, 17050-17055.
16. Chyung JH, Selkoe DJ (2003) Inhibition of receptor-mediated endocytosis demonstrates generation of amyloid beta-protein at the cell surface. J Biol Chem 278, 51035-51043.
17. Chyung JH, Raper DM, Selkoe DJ (2005) Gamma-secretase exists on the plasma membrane as an intact complex that accepts substrates and effects intramembrane cleavage. J Biol Chem 280, 4383-4392.
18. Buckig A, Tikkanen R, HerzogV, SchmitzA(2002) Cytosolic and nuclear aggregation of the amyloid beta-peptide following its expression in the endoplasmic reticulum. Histochem Cell Biol 118, 353-360.
19. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloidbeta in Alzheimer's disease. Nat Rev Neurosci 8, 499-509.
20. Selkoe DJ (2000) The genetics and molecular pathology of Alzheimer's disease: Roles of amyloid and the presenilins. Neurol Clin 18, 903-922.
21. Glabe C (2001) Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J Mol Neurosci 17, 137-145.
22. Irvine GB, El-Agnaf OM, Shankar GM, Walsh DM (2008) Protein aggregation in the brain: The molecular basis for Alzheimer's and Parkinson's diseases. Mol Med 14, 451- 464.
23. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8, 101-112.
24. Klein WL, Krafft GA, Finch CE (2001) Targeting small Abeta oligomers: The solution to an Alzheimer's disease conundrum Trends Neurosci 24, 219-224.
25. Walsh DM, Tseng BP, Rydel RE, Podlisny MB, Selkoe DJ (2000) The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry 39, 10831-10839.
26. Gouras GK, Tsai J, Naslund J,Vincent B, Edgar M, Checler F, Greenfield JP, HaroutunianV, Buxbaum JD, Xu H, Greengard P, Relkin NR (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156, 15-20.
27. Koistinaho M, Ort M, Cimadevilla JM, Vondrous R, Cordell B, Koistinaho J, Bures J, Higgins LS (2001) Specific spatial learning deficits become severe with age in beta -amyloid precursor protein transgenic mice that harbor diffuse beta - amyloid deposits but do not form plaques. Proc Natl Acad Sci U S A 98, 14675-14680.
28. Naslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, Buxbaum JD (2000) Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283, 1571-1577.
29. Tampellini D, Capetillo-Zarate E, Dumont M, Huang Z, Yu F, Lin MT, Gouras GK (2010) Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice. J Neurosci 30, 14299- 14304.
30. Tampellini D, Rahman N, LinMT, Capetillo-Zarate E, Gouras GK (2011) Impaired beta-amyloid secretion in Alzheimer's disease pathogenesis. J Neurosci 31, 15384-15390.
31. Nath S, Agholme L, Kurudenkandy FR, Granseth B, Marcusson J, Hallbeck M (2012) Spreading of neurodegenerative pathology via neuron-to-neuron transmission of beta-amyloid. J Neurosci 32, 8767-8777.
32. Nixon RA, CataldoAM,MathewsPM(2000) The endosomallysosomal system of neurons in Alzheimer's disease pathogenesis: A review. Neurochem Res 25, 1161-1172.
33. Adamec E, Mohan PS, Cataldo AM, Vonsattel JP, Nixon RA (2000) Up-regulation of the lysosomal system in experimental models of neuronal injury: Implications for Alzheimer's disease. Neuroscience 100, 663-675.
34. Yang AJ, Chandswangbhuvana D, Margol L, Glabe CG (1998) Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis. J Neurosci Res 52, 691-698.
35. Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, Beal MF, Xu H, Greengard P, Gouras GK (2002) Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 161, 1869-1879.
36. Yu WH, Cuervo AM, Kumar A, Peterhoff CM, Schmidt SD, Lee JH, Mohan PS, Mercken M, Farmery MR, Tjernberg LO, Jiang Y, Duff K, Uchiyama Y, Naslund J, Mathews PM, Cataldo AM, Nixon RA (2005) Macroautophagy-a novel beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J Cell Biol 171, 87-98.
37. Langui D, Girardot N, El Hachimi KH, Allinquant B, Blanchard V, Pradier L, Duyckaerts C (2004) Subcellular topography of neuronal Abeta peptide in APPxPS1 transgenic mice. Am J Pathol 165, 1465-1477.
38. Zheng L, Roberg K, Jerhammar F, Marcusson J, Terman A (2006) Autophagy of amyloid beta-protein in differentiated neuroblastoma cells exposed to oxidative stress. Neurosci Lett 394, 184-189.
39. Zheng L, Kagedal K, Dehvari N, Benedikz E, Cowburn R, Marcusson J, Terman A (2009) Oxidative stress induces macroautophagy of amyloid beta-protein and ensuing apoptosis. Free Radic Biol Med 46, 422-429.
40. Zheng L, Cedazo-Minguez A, Hallbeck M, Jerhammar F, Marcusson J, Terman A (2012) Intracellular distribution of amyloid beta peptide and its relationship to the lysosomal system. Transl Neurodegener 1, 19.
41. Zheng L, Roberg K, Jerhammar F, Marcusson J, Terman A (2006) Oxidative stress induces intralysosomal accumulation of Alzheimer amyloid beta-protein in cultured neuroblastoma cells. Ann N Y Acad Sci 1067, 248-251.
42. Zheng L, Terman A, Hallbeck M, Dehvari N, Cowburn RF, Benedikz E, Kagedal K, Cedazo-Minguez A, Marcusson J (2011) Macroautophagy-generated increase of lysosomal amyloid beta-protein mediates oxidant-induced apoptosis of cultured neuroblastoma cells. Autophagy 7, 1528-1545.
43. Kaether C, Schmitt S, Willem M, Haass C (2006) Amyloid precursor protein and Notch intracellular domains are generated after transport of their precursors to the cell surface. Traffic 7, 408-415.
44. Verderio C, Coco S, Bacci A, Rossetto O, De Camilli P, Montecucco C, Matteoli M (1999) Tetanus toxin blocks the exocytosis of synaptic vesicles clustered at synapses but not of synaptic vesicles in isolated axons. J Neurosci 19, 6723-6732.
45. Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS (2001) Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414, 643-648.
46. Vandersteen A, Hubin E, Sarroukh R, De Baets G, Schymkowitz J, Rousseau F, Subramaniam V, Raussens V, Wenschuh H, Wildemann D, Broersen K (2012) A comparative analysis of the aggregation behavior of amyloid-beta peptide variants. FEBS Lett 586, 4088-4093.
47. Grigoriev I, Yu KL, Martinez-Sanchez E, Serra-Marques A, Smal I, Meijering E, Demmers J, Peranen J, Pasterkamp RJ, van der Sluijs P, Hoogenraad CC, AkhmanovaA(2011) Rab6, Rab8, and MICAL3 cooperate in controlling docking and fusion of exocytotic carriers. Curr Biol 21, 967-974.
48. Diaz E, Schimmoller F, Pfeffer SR (1997)Anovel Rab9 effector required for endosome-to-TGN transport. J Cell Biol 138, 283-290.
49. Duner F, Patrakka J, Xiao Z, Larsson J, Vlamis-Gardikas A, Pettersson E,Tryggvason K, Hultenby K,WernersonA(2008) Dendrin expression in glomerulogenesis and in human minimal change nephrotic syndrome. Nephrol Dial Transplant 23, 2504-2511.
50. Katzmann DJ, Odorizzi G, Emr SD (2002) Receptor downregulation and multivesicular-body sorting. Nat Rev Mol Cell Biol 3, 893-905.
51. Pasternak SH, Callahan JW, Mahuran DJ (2004) The role of the endosomal/lysosomal system in amyloid-beta production and the pathophysiology of Alzheimer's disease: Reexamining the spatial paradox from a lysosomal perspective. J Alzheimers Dis 6, 53-65.
52. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688.
53. Lee EK, Park YW, Shin DY, Mook-Jung I, Yoo YJ (2006) Cytosolic amyloid-beta peptide 42 escaping from degradation induces cell death. Biochem Biophys Res Commun 344, 471- 477.
54. Moghekar A, Rao S, Li M, Ruben D, Mammen A, Tang X, O'Brien RJ (2011) Large quantities of Abeta peptide are constitutively released during amyloid precursor protein metabolism in vivo and in vitro. J Biol Chem 286, 15989- 15997.
55. Rajendran L, Annaert W (2012) Membrane trafficking pathways in Alzheimer's disease. Traffic 13, 759-770.
56. Muirhead KE, Borger E, Aitken L, Conway SJ, Gunn-Moore FJ (2010) The consequences of mitochondrial amyloid betapeptide in Alzheimer's disease. Biochem J 426, 255-270.
57. Schmitz A, Herzog V (2004) Endoplasmic reticulumassociated degradation: Exceptions to the rule. Eur J Cell Biol 83, 501-509.
58. Citron M, Vigo-Pelfrey C, Teplow DB, Miller C, Schenk D, Johnston J, Winblad B, Venizelos N, Lannfelt L, Selkoe DJ (1994) Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci U S A 91, 11993-11997.
59. Johnston JA, Cowburn RF, Norgren S,Wiehager B, Venizelos N,Winblad B, Vigo-Pelfrey C, Schenk D, Lannfelt L, O'Neill C(1994) Increased beta-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation. FEBS Lett 354, 274-278.
60. Rajendran L, Knobloch M, Geiger KD, Dienel S, Nitsch R, Simons K, Konietzko U (2007) Increased Abeta production leads to intracellular accumulation of Abeta in flotillin-1- positive endosomes. Neurodegener Dis 4, 164-170.
61. Oddo S, Caccamo A, Tran L, Lambert MP, Glabe CG, Klein WL, LaFerla FM (2006) Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease.Alink between Abeta and tau pathology. J Biol Chem 281, 1599-1604.
62. Kim SI, Yi JS, Ko YG (2006) Amyloid beta oligomerization is induced by brain lipid rafts. J Cell Biochem 99, 878-889.
63. Kawarabayashi T, Shoji M, Younkin LH,Wen-Lang L, Dickson DW, Murakami T, Matsubara E, Abe K, Ashe KH, Younkin SG (2004) Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 24, 3801-3809.
64. Blott EJ, Griffiths GM (2002) Secretory lysosomes. Nat Rev Mol Cell Biol 3, 122-131.
65. Munro S, Pelham HR (1987) A C-terminal signal prevents secretion of luminal ER proteins. Cell 48, 899-907.
66. Dean N, Pelham HR (1990) Recycling of proteins from the Golgi compartment to the ER in yeast. J Cell Biol 111, 369- 377.
67. McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, Skipper L, Murphy MP, Beard J, Das P, Jansen K, Delucia M, Lin WL, Dolios G, Wang R, Eckman CB, Dickson DW, Hutton M, Hardy J, Golde T (2005) Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47, 191-199.
68. Tampellini D, Gouras GK (2010) Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease. Front Aging Neurosci 2, doi:pii: 13. 10.3389/fnagi.2010.00013.
69. Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Schoepp DD, Paul SM, Mennerick S, HoltzmanDM (2005) Synaptic activity regulates interstitial fluid amyloidbeta levels in vivo. Neuron 48, 913-922.
70. Zhu XC, Yu JT, Jiang T, Tan L (2013) Autophagy modulation for Alzheimer's disease therapy. Mol Neurobiol, doi: 10.1007/s12035-013-8457-z.
71. FengY,WangX(2012) Antioxidant therapies for Alzheimer's disease. Oxid Med Cell Longev 2012, 472932.